Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,506 | 23,081 | 19,807 | 10,479 | 16,615 |
| Marketable Securities | N/A | N/A | N/A | N/A | 2,099 |
| Other current assets | 0 | 268 | 233 | 184 | 356 |
| TOTAL | $93,994 | $23,349 | $20,040 | $10,663 | $19,070 |
| Non-Current Assets | |||||
| PPE Net | 11 | 47 | 87 | 156 | 232 |
| Other Non-Current Assets | 295 | 90 | 12 | 12 | 0 |
| TOTAL | $306 | $137 | $99 | $168 | $232 |
| Total Assets | $94,300 | $23,486 | $20,139 | $10,831 | $19,302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 911 | 453 | 294 | 424 | 303 |
| Accrued Expenses | 802 | 835 | 217 | 708 | 362 |
| Other current liabilities | 94 | 9 | N/A | N/A | N/A |
| TOTAL | $1,865 | $1,387 | $511 | $1,132 | $665 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 235 | 0 | 0 | 0 | 0 |
| TOTAL | $235 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,100 | $1,387 | $511 | $1,132 | $665 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,898 | 24,730 | 17,219 | 6,596 | 6,594 |
| Common Shares | 35 | 22 | 17 | 7 | 7 |
| Retained earnings | -174,921 | -168,587 | -163,956 | -157,399 | -145,488 |
| TOTAL | $92,200 | $22,099 | $19,628 | $9,699 | $18,637 |
| Total Liabilities And Equity | $94,300 | $23,486 | $20,139 | $10,831 | $19,302 |